Soliton News - SOLY

Best deals to access real time data!
CHART Trader Monthly Subscription for only ~~$30.66~~
Canadian Level 1 + USA Monthly Subscription for only ~~$38.05~~
Small Cap Basic Monthly Subscription for only ~~$33.03~~
VAT not included

Company Name	Stock Ticker Symbol	Market	Type
Soliton Inc	SOLY	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	High Price	Low Price	Open Price	Close Price	Last Traded
	0.00	0.0%	10.32	10.46	10.15	10.31	10.32	23:59:46

more quote information »

Recent News

Date	Time	Source	Heading
12/10/2019	08:00	PRNUS	Soliton Appoints Mary Stoll as Senior Director of Clinical..
12/03/2019	08:00	PRNUS	Soliton Initiates Significant Step Towards Commercialization
11/25/2019	06:03	EDGAR	Notice of Effectiveness (effect)
11/22/2019	16:05	EDGAR	Current Report Filing (8-k)
11/21/2019	08:00	PRNUS	Soliton and Emphysys Enter Into a 3-year Development..
11/12/2019	08:00	PRNUS	Soliton Announces First Follow-up Visit Conducted in the..
11/08/2019	16:13	EDGAR	Securities Registration Statement (s-1)
11/07/2019	16:30	EDGAR	Quarterly Report (10-q)
11/05/2019	09:00	PRNUS	Soliton Completes Treatment of All Patients in Pivotal..
10/29/2019	08:00	PRNUS	Soliton's Recent Positive Data Increases Potential Fibrotic..
10/25/2019	08:00	PRNUS	Soliton Announces Positive Interim Clinical Trial Results..
10/21/2019	08:00	PRNUS	Soliton to Announce Keloid Trial Data on October 25, 2019..
10/16/2019	06:02	EDGAR	Amended Statement of Beneficial Ownership (sc 13d/a)
10/15/2019	18:09	EDGAR	Statement of Changes in Beneficial Ownership (4)
10/15/2019	16:15	EDGAR	Current Report Filing (8-k)
10/15/2019	08:00	PRNUS	Soliton's FDA Cleared RAP Device is Granted Two Additional..
10/10/2019	08:30	PRNUS	Soliton Announces $6.25 Million Private Placement
10/08/2019	08:00	PRNUS	Soliton to Announce Keloid and Hypertrophic Scar Clinical..
10/03/2019	08:00	PRNUS	Soliton Announces Tattoo Technology Article Published in..
10/01/2019	08:00	PRNUS	Soliton Completes Keloid POC Clinical Trial Treatments
9/24/2019	08:00	PRNUS	Soliton Announces Majority of Patients Treated in Pivotal..
9/19/2019	16:16	EDGAR	Current Report Filing (8-k)
9/19/2019	08:45	PRNUS	Soliton Begins Treatments In Proof-Of-Concept Trial For..
9/17/2019	08:00	PRNUS	Soliton Completes Trial Enrollment and Conducts Initial Site..
9/10/2019	08:00	PRNUS	Soliton Announces Site Selected for Clinical Trial to Treat..
9/09/2019	08:32	EDGAR	Current Report Filing (8-k)
9/09/2019	08:00	PRNUS	Soliton Releases Letter to Shareholders
9/04/2019	08:00	PRNUS	Soliton Announces IRB Approval for Keloid Trial
8/29/2019	08:00	PRNUS	Soliton to Initiate POC Clinical Trials to Treat Fibrotic..
8/26/2019	17:02	EDGAR	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/26/2019	08:00	PRNUS	Soliton Engages argodesign in Preparation of Commercial..
8/26/2019	06:00	EDGAR	Notice of Effectiveness (effect)
8/20/2019	08:00	PRNUS	Soliton Announces Positive Results Demonstrated from Longer..
8/16/2019	08:00	PRNUS	Dr. Michael Kaminer Presented Soliton RAP for Cellulite at..
8/14/2019	08:00	PRNUS	Soliton Treats First Patients in Pivotal Cellulite Trial
8/12/2019	08:00	PRNUS	Soliton Announces Patient Recruitment Has Begun for Pivotal..
8/09/2019	17:12	EDGAR	Quarterly Report (10-q)
8/06/2019	17:03	EDGAR	Securities Registration Statement (s-1/a)
8/06/2019	08:00	PRNUS	Soliton Completes Site Enrollment and Conducts Initial Site..
8/05/2019	08:00	PRNUS	Soliton Partners with Clear Dermatology and Aesthetics..
8/01/2019	09:28	PRNUS	Soliton Announces Global Nasdaq Partner Sanmina Delivers RAP..
7/29/2019	08:00	PRNUS	Soliton Announces IRB Approval
7/25/2019	08:00	PRNUS	Soliton Enlists Chicago Cosmetic Surgery and Dermatology to..
7/23/2019	08:00	PRNUS	Soliton's FDA Cleared Device is Granted Key Patent
7/16/2019	08:00	PRNUS	Soliton Announces Submission for IRB Approval of Pivotal..
7/15/2019	17:01	EDGAR	Current Report Filing (8-k)
7/15/2019	08:00	PRNUS	Soliton Announces Positive 26-week Cellulite Clinical Trial..
7/12/2019	17:02	EDGAR	Securities Registration: Employee Benefit Plan (s-8)
7/10/2019	08:00	PRNUS	Soliton Expands Clinical Trial Sites to include SkinCare..
7/08/2019	08:00	PRNUS	Soliton to Announce Cellulite Trial Data for 26-Week Period..

See more news about this stock »

Soliton News - SOLY

Recent News

SOLY Historical - 1 Day

SOLY Historical - 1 Year